![NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)](/_next/image?url=https%3A%2F%2Fd1pbbaszqas6uj.cloudfront.net%2FOpportunity_Thumbnail%2Fd079360bc411b28d.png&w=3840&q=75)
Closed
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Grant
About
The NIH, CDC, and FDA are offering the Small Business Innovation Research (SBIR) grant to support U.S.-owned small businesses in conducting research and development aimed at commercializing innovative health technologies, with multiple application deadlines and phases to accommodate various project stages.
Benefits
- 💰Financial SupportAccess to early-stage funding
- 🛠️ Technology Development SupportSupport for technology development
- 📈Commercialization PotentialPotential for commercialization of innovative products
Eligibility Criteria
- Must be a U.S.-owned small business
- Must propose R&D for commercialization
- Principal investigator must be primarily employed by the small business
Participation Commitments
- Conduct majority of research or analytical effort
- Submit progress reports as required
- Engage with program staff prior to application
Target Sector
Health Technology
Target Location
United States
Want to discover more opportunities like this?
Join StartupLinkX for free and get matched with relevant funding, competitions, grants, and more.
Found an issue with this listing?
NIH, CDC, FDA